Guanylate-binding protein-1 is a potential new therapeutic target for triple-negative breast cancer

BACKGROUND: Triple-negative breast cancer (TNBC) is characterized by a lack of estrogen and progesterone receptor expression (ESR and PGR, respectively) and an absence of human epithelial growth factor receptor (ERBB2) amplification. Approximately 15–20% of breast malignancies are TNBC. Patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Quintero, Melissa, Adamoski, Douglas, Reis, Larissa Menezes dos, Ascenção, Carolline Fernanda Rodrigues, Oliveira, Krishina Ratna Sousa de, Gonçalves, Kaliandra de Almeida, Dias, Marília Meira, Carazzolle, Marcelo Falsarella, Dias, Sandra Martha Gomes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5688804/
https://www.ncbi.nlm.nih.gov/pubmed/29115931
http://dx.doi.org/10.1186/s12885-017-3726-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5688804/
https://www.ncbi.nlm.nih.gov/pubmed/29115931
http://dx.doi.org/10.1186/s12885-017-3726-2

Ejemplares similares